Aberrant activation of mTOR signaling is found in approximately half of HCC cases, largely due to alterations of upstream tumor suppressors and oncogenes, including PI3K, AKT, PTEN and TSC1/2 [12]. Here, PTEN is linked to hepatocellular carcinoma.